Por: Los Angeles Times Science January 24, 2023
U.S. health officials want to make COVID-19 vaccinations more like the annual flu shot. The Food and Drug Administration on Monday proposed a simplified approach for future vaccination efforts, allowing most adults and children to get a once-a-year shot to protect against the mutating virus. This means Americans would no longer have to keep track of how many shots they’ve received or how many months it’s been since their last booster. The... + full article
The Hill USA Health January 27, 2023
A key FDA committee voted to update the current vaccination strategy against COVID-19, signaling a shift in how the U.S. will handle the virus going into the fourth year of the pandemic. Welcome to The Hill’s Health Care roundup, where we’re following the latest moves on... + más
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy | Politico
Best TV Show bracket: Here’s how you voted in Rounds 1 and 2 | The Boston Globe
Politico USA Health December 30, 2022
The FDA’s collaboration with Biogen, the maker of a controversial Alzheimer’s drug, before it granted the product accelerated approval was “atypical” and ran afoul of the agency’s protocol for documenting interactions with drug companies, according to a joint House... + más
Alzheimer's drug approval by FDA 'rife with irregularities,' probe finds | Los Angeles Times
Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News
NBC 6 South Florida USA World December 30, 2022
Adam Glanzman Bloomberg Getty Images The ’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.” The 18-month investigation by two House committees detailed... + más
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial | CNBC
ABC News USA Health December 20, 2022
WASHINGTON -- The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más
Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press
Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10
WPLG Local 10 USA Politics December 20, 2022
WASHINGTON – The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más
Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News
Associated Press USA Politics December 19, 2022
WASHINGTON (AP) — The lack of clear direction and priorities at the U.S. Food and Drug Administration’s tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | WPLG Local 10
About iurex | Privacy Policy | Disclaimer |